Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Lander

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Proceedings of the Australian Association of Neurologists|January 1, 1975
Interactions between anticonvulsantsC M Lander, M J Eadie, J H Tyrer
Lancet (London, England)|December 2, 1978
Tiapride and sulpiride in Parkinson's diseaseA J Lees, C M Lander, G M Stern
Clinical and Experimental Neurology|January 1, 1977
Factors influencing plasma carbamazepine concentrationsC M Lander, M J Eadie, J H Tyrer
Journal of Neural Transmission. Supplementum|January 1, 1980
Akinetic freezing and trick movements in Parkinson's diseaseG M Stern, C M Lander, A J Lees
Clinical and Experimental Neurology|January 1, 1981
The clearance of anticonvulsant drugs in pregnancyC M Lander, I Livingstone, J H Tyrer, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 9, 2000
Chronic inflammatory demyelinating polyradiculoneuropathy and severe peripheral oedema: a renal explanationR D Henderson, H G Healy, P A McCombe, et al.
Neurology|February 1, 1977
Plasma anticonvulsant concentrations during pregnancyC M Lander, V E Edwards, M J Eadie, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
The role of bromocriptine in the treatment of Parkinson's diseaseG M Stern, A J Lees, K M Shaw, et al.
British Journal of Clinical Pharmacology|October 1, 1977
Factors influencing plasma phenobarbitone levels in epileptic patientsM J Eadie, C M Lander, W D Hooper, et al.
Proceedings of the Australian Association of Neurologists|January 1, 1976
The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patientsM J Eadie, C M Lander, W D Hooper, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Proceedings of the Australian Association of Neurologists|January 1, 1975
Interactions between anticonvulsantsC M Lander, M J Eadie, J H Tyrer
Lancet (London, England)|December 2, 1978
Tiapride and sulpiride in Parkinson's diseaseA J Lees, C M Lander, G M Stern
Clinical and Experimental Neurology|January 1, 1977
Factors influencing plasma carbamazepine concentrationsC M Lander, M J Eadie, J H Tyrer
Journal of Neural Transmission. Supplementum|January 1, 1980
Akinetic freezing and trick movements in Parkinson's diseaseG M Stern, C M Lander, A J Lees
Clinical and Experimental Neurology|January 1, 1981
The clearance of anticonvulsant drugs in pregnancyC M Lander, I Livingstone, J H Tyrer, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 9, 2000
Chronic inflammatory demyelinating polyradiculoneuropathy and severe peripheral oedema: a renal explanationR D Henderson, H G Healy, P A McCombe, et al.
Neurology|February 1, 1977
Plasma anticonvulsant concentrations during pregnancyC M Lander, V E Edwards, M J Eadie, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
The role of bromocriptine in the treatment of Parkinson's diseaseG M Stern, A J Lees, K M Shaw, et al.
British Journal of Clinical Pharmacology|October 1, 1977
Factors influencing plasma phenobarbitone levels in epileptic patientsM J Eadie, C M Lander, W D Hooper, et al.
Proceedings of the Australian Association of Neurologists|January 1, 1976
The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patientsM J Eadie, C M Lander, W D Hooper, et al.
Pageof 5